CH645532A5 - Prothese de vaisseau sanguin. - Google Patents
Prothese de vaisseau sanguin. Download PDFInfo
- Publication number
- CH645532A5 CH645532A5 CH82281A CH82281A CH645532A5 CH 645532 A5 CH645532 A5 CH 645532A5 CH 82281 A CH82281 A CH 82281A CH 82281 A CH82281 A CH 82281A CH 645532 A5 CH645532 A5 CH 645532A5
- Authority
- CH
- Switzerland
- Prior art keywords
- blood vessel
- vessel prosthesis
- absorbable
- prosthesis according
- wall
- Prior art date
Links
- 210000004204 blood vessel Anatomy 0.000 title claims description 20
- 239000000463 material Substances 0.000 claims description 61
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 11
- 210000000601 blood cell Anatomy 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 4
- -1 polyethylene terephthalates Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims 3
- 230000002792 vascular Effects 0.000 description 17
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 210000003038 endothelium Anatomy 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 229920002994 synthetic fiber Polymers 0.000 description 7
- 229960004275 glycolic acid Drugs 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 229920004934 Dacron® Polymers 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 230000002965 anti-thrombogenic effect Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- GZYXPXGNODDCBD-UHFFFAOYSA-N 3,3,6,6-tetramethyl-1,4-dioxane-2,5-dione Chemical compound CC1(C)OC(=O)C(C)(C)OC1=O GZYXPXGNODDCBD-UHFFFAOYSA-N 0.000 description 1
- ULKFLOVGORAZDI-UHFFFAOYSA-N 3,3-dimethyloxetan-2-one Chemical compound CC1(C)COC1=O ULKFLOVGORAZDI-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- GSCLMSFRWBPUSK-UHFFFAOYSA-N beta-Butyrolactone Chemical compound CC1CC(=O)O1 GSCLMSFRWBPUSK-UHFFFAOYSA-N 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7904938A SE424401B (sv) | 1979-06-06 | 1979-06-06 | Blodkerlsprotes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH645532A5 true CH645532A5 (fr) | 1984-10-15 |
Family
ID=20338221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH82281A CH645532A5 (fr) | 1979-06-06 | 1980-06-04 | Prothese de vaisseau sanguin. |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS6318508B2 (OSRAM) |
| AU (1) | AU539875B2 (OSRAM) |
| BE (1) | BE883646A (OSRAM) |
| CA (1) | CA1166802A (OSRAM) |
| CH (1) | CH645532A5 (OSRAM) |
| DE (1) | DE3047573T1 (OSRAM) |
| FR (1) | FR2458274A1 (OSRAM) |
| GB (1) | GB2063685B (OSRAM) |
| NL (1) | NL8020201A (OSRAM) |
| SE (1) | SE424401B (OSRAM) |
| WO (1) | WO1980002641A1 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483339A (en) * | 1982-01-29 | 1984-11-20 | Rolando Gillis | Vascular surgery roll |
| GB8302003D0 (en) * | 1983-01-25 | 1983-02-23 | Vascutek Ltd | Vascular prosthesis |
| SE446372B (sv) * | 1983-02-03 | 1986-09-08 | Medinvent Sa | Blodkerlsprotes for anvendning som shunt mellan blodkerl |
| FR2541888B1 (fr) * | 1983-03-04 | 1989-04-21 | Sgro Jean Claude | Prothese vasculaire partiellement resorbable |
| JPS59225052A (ja) * | 1983-06-07 | 1984-12-18 | 東レ株式会社 | 人工血管 |
| US4670286A (en) * | 1983-09-20 | 1987-06-02 | Allied Corporation | Method of forming prosthetic devices |
| US4687482A (en) * | 1984-04-27 | 1987-08-18 | Scripps Clinic And Research Foundation | Vascular prosthesis |
| US4923470A (en) * | 1985-04-25 | 1990-05-08 | American Cyanamid Company | Prosthetic tubular article made with four chemically distinct fibers |
| US4792336A (en) * | 1986-03-03 | 1988-12-20 | American Cyanamid Company | Flat braided ligament or tendon implant device having texturized yarns |
| US4716900A (en) * | 1986-05-09 | 1988-01-05 | Pfizer Hospital Products Group, Inc. | Intraintestinal bypass graft |
| EP0334045B1 (en) * | 1988-03-22 | 1994-08-17 | American Cyanamid Company | Prosthetic article |
| JPH0677600B2 (ja) * | 1989-02-07 | 1994-10-05 | テルモ株式会社 | 生体器官用補綴材 |
| CH677186A5 (OSRAM) * | 1989-02-28 | 1991-04-30 | Sulzer Ag | |
| US5632776A (en) * | 1990-11-22 | 1997-05-27 | Toray Industries, Inc. | Implantation materials |
| EP1010406B1 (en) | 1994-06-08 | 2005-02-02 | Cardiovascular Concepts, Inc. | Endoluminal graft |
| ES2206581T3 (es) * | 1995-06-07 | 2004-05-16 | Edwards Lifesciences Corporation | Injerto vascular con cinta de refuerzo y soporte externo. |
| US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
| US6174330B1 (en) | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
| US5980564A (en) * | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
| US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
| US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
| US6156064A (en) | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
| US6206883B1 (en) | 1999-03-05 | 2001-03-27 | Stryker Technologies Corporation | Bioabsorbable materials and medical devices made therefrom |
| US6747121B2 (en) | 2001-09-05 | 2004-06-08 | Synthes (Usa) | Poly(L-lactide-co-glycolide) copolymers, methods for making and using same, and devices containing same |
| JP3970013B2 (ja) * | 2001-12-14 | 2007-09-05 | 泰晴 野一色 | 管腔形成誘導性材料および体内挿入用器具 |
| JP2005034239A (ja) * | 2003-07-16 | 2005-02-10 | Gunze Ltd | 人工血管用基材 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH472219A (de) * | 1963-06-15 | 1969-05-15 | Spofa Vereinigte Pharma Werke | Hochporöse Kollagen-Gewebe-Blutgefässprothese und Verfahren zur Herstellung derselben |
| US3463158A (en) * | 1963-10-31 | 1969-08-26 | American Cyanamid Co | Polyglycolic acid prosthetic devices |
| DE2017330A1 (en) * | 1970-04-10 | 1971-12-09 | BIO-CAL Instrument GmbH, 8032 Gräfelfing | Blood vessel connector - for artificial kidneys or lungs |
| BE758156R (fr) * | 1970-05-13 | 1971-04-28 | Ethicon Inc | Element de suture absorbable et sa |
| US3688317A (en) * | 1970-08-25 | 1972-09-05 | Sutures Inc | Vascular prosthetic |
| US3982543A (en) * | 1973-04-24 | 1976-09-28 | American Cyanamid Company | Reducing capillarity of polyglycolic acid sutures |
| US3914802A (en) * | 1974-05-23 | 1975-10-28 | Ebert Michael | Non-thrombogenic prosthetic material |
| JPS515897A (en) * | 1974-07-02 | 1976-01-19 | Hiroshi Matsumoto | Jinkoketsukan oyobi sonoseizohoho |
| JPS5287894A (en) * | 1975-12-02 | 1977-07-22 | Rhone Poulenc Ind | Transplanting surgical tube |
| US4086665A (en) * | 1976-12-16 | 1978-05-02 | Thermo Electron Corporation | Artificial blood conduit |
| US4130904A (en) * | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
-
1979
- 1979-06-06 SE SE7904938A patent/SE424401B/sv unknown
-
1980
- 1980-06-04 NL NL8020201A patent/NL8020201A/nl not_active Application Discontinuation
- 1980-06-04 WO PCT/SE1980/000161 patent/WO1980002641A1/en not_active Ceased
- 1980-06-04 JP JP55501198A patent/JPS6318508B2/ja not_active Expired
- 1980-06-04 CH CH82281A patent/CH645532A5/fr not_active IP Right Cessation
- 1980-06-04 AU AU59897/80A patent/AU539875B2/en not_active Ceased
- 1980-06-04 DE DE803047573T patent/DE3047573T1/de active Granted
- 1980-06-04 GB GB8103147A patent/GB2063685B/en not_active Expired
- 1980-06-05 BE BE0/200895A patent/BE883646A/fr not_active IP Right Cessation
- 1980-06-05 FR FR8012488A patent/FR2458274A1/fr active Granted
- 1980-06-06 CA CA000353650A patent/CA1166802A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU539875B2 (en) | 1984-10-18 |
| DE3047573C2 (OSRAM) | 1990-06-28 |
| AU5989780A (en) | 1980-12-22 |
| SE424401B (sv) | 1982-07-19 |
| SE7904938L (sv) | 1980-12-07 |
| FR2458274A1 (fr) | 1981-01-02 |
| JPS56500760A (OSRAM) | 1981-06-11 |
| GB2063685B (en) | 1983-05-18 |
| GB2063685A (en) | 1981-06-10 |
| BE883646A (fr) | 1980-10-01 |
| WO1980002641A1 (en) | 1980-12-11 |
| JPS6318508B2 (OSRAM) | 1988-04-19 |
| CA1166802A (en) | 1984-05-08 |
| NL8020201A (nl) | 1981-03-31 |
| FR2458274B1 (OSRAM) | 1983-12-09 |
| DE3047573T1 (de) | 1982-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2458274A1 (fr) | Prothese de vaisseau sanguin | |
| US4416028A (en) | Blood vessel prosthesis | |
| US4670286A (en) | Method of forming prosthetic devices | |
| US4594407A (en) | Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols | |
| DE60021309T3 (de) | Gefässtransplantat mit verbesserter orberflächenströmung | |
| EP0603959B1 (fr) | Endoprothèse luminale et son procédé de préparation | |
| Nakayama et al. | In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube) | |
| Vacanti et al. | Tissue engineered growth of new cartilage in the shape of a human ear using synthetic polymers seeded with chondrocytes | |
| US4712553A (en) | Sutures having a porous surface | |
| Doi et al. | Novel compliant and tissue‐permeable microporous polyurethane vascular prosthesis fabricated using an excimer laser ablation technique | |
| Guidoin et al. | Albumin coating of a knitted polyester arterial prosthesis: an alternative to preclotting | |
| FR2699066A1 (fr) | Greffe vasculaire formant prothèse. | |
| FR2924330A1 (fr) | Implant pour hernie parastomiale | |
| JPWO2011096402A1 (ja) | 生体適合性器具 | |
| EP3185817A1 (en) | Implantable devices comprising graft membranes | |
| FR2857851A1 (fr) | Implant prothetique formant ecran anti-adherence utilise notamment dans le domaine de la chirurgie parietale | |
| WO2006015161A3 (en) | Metallic drug-releasing medical devices and method of making same | |
| FR2604085A1 (fr) | Plaque d'osteosynthese pour la contention et la reduction d'effondrement des planchers orbitaires | |
| WO2023170408A1 (en) | Vascular stent | |
| FR2717069A1 (fr) | Prothèse médicale, telle qu'un filtre sanguin, pourvue d'un revêtement limitant l'adhérence ou le développement cellulaire. | |
| FR2737106A1 (fr) | Plaque de reconstitution a structure fibrillaire, souple et a memoire, pour le domaine de la chirurgie viscerale | |
| EP0943298A2 (fr) | Plaque chirurgicale | |
| WO2000071179A1 (en) | Expanded polytetrafluoroethylene vascular graft with increased healing response | |
| WO2019235543A1 (ja) | 多孔質体、及び、医療用材料 | |
| FR2651994A1 (fr) | Ligament prothetique comportant une armature de fibres synthetiques ou naturelles impregnees de collagene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |